Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer

Recruiting now

Conditions studied: Vulva Cancer, Sentinel Lymph Node

In brief

The aim of the study is to evaluate the feasibility of applying the SLN mapping technique in combination with FDG-PET/CT imaging in women with vulva cancer tumour size \>4 cm, multifocal tumors and local recurrences.

Key facts

Study ID

NCT06161428

Run by

Rigshospitalet, Denmark

People needed

100

Starts

2023-05-01

Expected to finish

2027-07-01

Last updated by the study team

2023-12-13

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients with vulva cancer, tumor > 4 cm, multifocal tumor, or local recurrences in vulva

You may not qualify if…

• Previous external irradiation of the vulva or groins
• Former sentinel node or inguinal lymphadenectomy in the relevant groin
• Known allergy to ICG or iodine
• Patient is in active treatment for other cancer and/or disseminated disease

Where it is running

• Copenhagen University Hospital — Copenhagen, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.